作者:Owen B. Wallace、Kenneth S. Lauwers、Jeffrey A. Dodge、Scott A. May、Joel R. Calvin、Ronald Hinklin、Henry U. Bryant、Pamela K. Shetler、Mary D. Adrian、Andrew G. Geiser、Masahiko Sato、Thomas P. Burris
DOI:10.1021/jm0509795
日期:2006.2.1
A selective estrogen receptor modulator (SERM) for the potential treatment of hot flushes is described. (R)-(+)-7,9-difluoro-5-[4-(2-piperidin-1-ylethoxy)phenyl]-5H-6-oxachrysen-2-ol, LSN2120310, potently binds ER alpha and ER beta and is an antagonist in MCF-7 breast adenocarcinoma and Ishikawa uterine cancer cell lines. The compound is a potent estrogen antagonist in the rat uterus. In ovariectomized rats, the compound lowers cholesterol, maintains bone mineral density, and is efficacious in a morphine dependent rat model of hot flush efficacy.